6078.HK Stock Analysis
60
Uncovered
Hygeia Healthcare Holdings Co Ltd is uncovered by Eyestock quantitative analysis.
Rating
To assess the quality of a company's business, we have collected all financial data from the statements and presented them in the form of a single number - the company's rating. Rating value of 100 is the threshold for determining a viable investment.
Moderate score
Market cap $B
1.222
Dividend yield
0.38 %
Shares outstanding
631.52 B
Hygeia Healthcare Holdings Co., Ltd. operates as a biopharmaceutical company that focuses on the development of new clinical drugs. The company is headquartered in Shanghai, Shanghai. The company went IPO on 2020-06-29. Through its subsidiaries, the Company mainly operates three segments. The Hospital Business segment provides outpatient and inpatient services for patients through its own hospitals. The Radiotherapy Business segment provides radiotherapy center consulting services, as well as the leasing, sales, disposal, and post-sales repair and maintenance services of radiotherapy equipment. The Hospital Management Service segment provides management related services to other hospitals. The firm conducts its businesses in the domestic market.